Home › Funds › TANAKA CAPITAL MANAGEMENT INC › CORT
TANAKA CAPITAL MANAGEMENT INC position in CORT
CORCEPT THERAPEUTICS INC · Health Care
TANAKA CAPITAL MANAGEMENT INC reported holding 110,854 shares of CORT (CORCEPT THERAPEUTICS INC) in its Q1 2026 13F filing — a position valued at US$4.5M, representing 7.46% of its reported portfolio and ranking #3 among its reported holdings. TANAKA CAPITAL MANAGEMENT INC has disclosed CORT holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How TANAKA CAPITAL MANAGEMENT INC's CORT position evolved
TANAKA CAPITAL MANAGEMENT INC first disclosed a stake in CORT in Q3 2023 at 37,569 shares (US$1.0M). The position peaked in Q1 2025 at 93,184 shares, worth US$10.6M. Across 8 filings, TANAKA CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 3 time(s) and left it unchanged 2 time(s). The most recent filing (Q1 2026) shows 110,854 shares valued at US$4.5M. Notable position changes include a 202% increase in Q3 2024 (shares rose 9% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 37.57K | $1.02M | New |
| Q4 2023 | 37.09K | $1.21M | Reduce |
| Q3 2024 | 112.14K | $5.19M | Add |
| Q4 2024 | 111.55K | $5.62M | Reduce |
| Q1 2025 | 93.18K | $10.64M | Reduce |
| Q3 2025 | 111.21K | $9.24M | Add |
| Q4 2025 | 111.08K | $3.87M | Hold |
| Q1 2026 | 110.85K | $4.47M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CORT and 13F data
CORT (CORCEPT THERAPEUTICS INC) is a Health Care company. 39 other funds we track also report a position in CORT — the largest reported positions include Renaissance Technologies (US$457.5M), Parallel Advisors, LLC (US$344.5M), TANG CAPITAL MANAGEMENT LLC (US$130.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CORT
- Renaissance Technologies 5.26M sh · $457.50M · Q2 2026
- Parallel Advisors, LLC 3.96M sh · $344.51M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 1.50M sh · $130.43M · Q2 2026
- MPM BioImpact LLC 771.03K sh · $67.04M · Q2 2026
- EMERALD ADVISERS, LLC 748.33K sh · $65.07M · Q2 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 464.90K sh · $40.42M · Q2 2026
- PERCEPTIVE ADVISORS LLC 398.38K sh · $34.64M · Q2 2026
More on TANAKA CAPITAL MANAGEMENT INC
FAQ
How long has TANAKA CAPITAL MANAGEMENT INC held CORT?
TANAKA CAPITAL MANAGEMENT INC has disclosed CORT holdings in 8 of the last 11 reported quarters, going back to Q3 2023.
What is TANAKA CAPITAL MANAGEMENT INC's current position in CORT?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 110.85K shares of CORT (CORCEPT THERAPEUTICS INC), valued at $4.47M, representing 7.46% of its reported portfolio and ranking #3.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling CORT?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC held unchanged its position in CORT. The position peaked in Q1 2025 at 93.18K shares.
Which other funds hold CORT?
Other major institutional holders of CORT include Renaissance Technologies, Parallel Advisors, LLC, TANG CAPITAL MANAGEMENT LLC, among 39 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.